{"title":"Association between Suicidal Ideation and Immune Parameters in Firstepisode Patients with Schizophrenia.","authors":"Yu Xia, Xiaoni Guan, Meihong Xiu, Fengchun Wu","doi":"10.2174/011570159X384619250727094057","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Disturbed immunity and inflammation have been associated with the pathogenesis of schizophrenia (SZ) and suicidal behaviors. We hypothesized that the neutrophil-tolymphocyte ratio (NLR) was associated with the increased risk of suicide ideation (SI) in patients with SZ.</p><p><strong>Methods: </strong>A total of 97 drug-naïve first-episode patients with SZ (15 with SI and 82 without SI) were recruited in the present study. The symptom severity was assessed using the Positive and Negative Syndrome Scale (PANSS), and differential white cell counts and SI were assessed for all patients.</p><p><strong>Results: </strong>Patients in the SI group had higher NLR values and more severe clinical symptoms than the non-SI group (all p<0.05). Differences remained significant when controlling for smoking, sex, BMI, and age. Logistic regression analysis showed that NLR values were an independent predictor of SI in first-episode patients with SZ after controlling for clinical symptoms, smoking status, marital status, education, sex, body mass index (BMI), and age.</p><p><strong>Discussion: </strong>This study indicates a predictive role of NLR in SI at the first onset of SZ. It also suggests that monitoring NLR could be a useful clinical tool for identifying patients who may be at higher risk for SI, particularly at the onset of the disorder.</p><p><strong>Conclusion: </strong>Our findings add to the understanding of the biological factors that may contribute to SI in SZ.</p>","PeriodicalId":10905,"journal":{"name":"Current Neuropharmacology","volume":" ","pages":""},"PeriodicalIF":5.3000,"publicationDate":"2025-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Neuropharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2174/011570159X384619250727094057","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Disturbed immunity and inflammation have been associated with the pathogenesis of schizophrenia (SZ) and suicidal behaviors. We hypothesized that the neutrophil-tolymphocyte ratio (NLR) was associated with the increased risk of suicide ideation (SI) in patients with SZ.
Methods: A total of 97 drug-naïve first-episode patients with SZ (15 with SI and 82 without SI) were recruited in the present study. The symptom severity was assessed using the Positive and Negative Syndrome Scale (PANSS), and differential white cell counts and SI were assessed for all patients.
Results: Patients in the SI group had higher NLR values and more severe clinical symptoms than the non-SI group (all p<0.05). Differences remained significant when controlling for smoking, sex, BMI, and age. Logistic regression analysis showed that NLR values were an independent predictor of SI in first-episode patients with SZ after controlling for clinical symptoms, smoking status, marital status, education, sex, body mass index (BMI), and age.
Discussion: This study indicates a predictive role of NLR in SI at the first onset of SZ. It also suggests that monitoring NLR could be a useful clinical tool for identifying patients who may be at higher risk for SI, particularly at the onset of the disorder.
Conclusion: Our findings add to the understanding of the biological factors that may contribute to SI in SZ.
期刊介绍:
Current Neuropharmacology aims to provide current, comprehensive/mini reviews and guest edited issues of all areas of neuropharmacology and related matters of neuroscience. The reviews cover the fields of molecular, cellular, and systems/behavioural aspects of neuropharmacology and neuroscience.
The journal serves as a comprehensive, multidisciplinary expert forum for neuropharmacologists and neuroscientists.